TAN-SNIP AIM 1: long term impact evaluation of a worksite-based lifestyle intervention to reduce imaging characterized-cardiovascular risk in office workers: Two parallel randomized controlled trials (WC2015-002)

Staff and Partners

Starting date: 01/01/2015

TANSNIP is a Trans-Atlantic Network to study Stepwise Non-invasive Imaging as a tool for CVD Prognosis and prevention. The network consists of experts in the fields of CVD imaging, diagnostics, worksite health promotion and clinical trials that are carrying out several studies in this field. The current study is one of those TANSNIP studies and links to the ongoing cohort study “Progression and Early detection of Subclinical Atheresclerosis” (PESA: NCT01410318). The ongoing PESA cohort started in 2010 and consists of 4066 asymptomatic male and female bank employees of the Banco de Santander Headquarters in Madrid (Spain). PESA evaluates the presence and progression of subclinical atherosclerotic lesions in the carotid, aortic, coronary and ilio-femoral territories using noninvasive advanced 2D/3D ultrasound imaging techniques.

VUmc, department Public and Occupational Health, Amsterdam:

PI: Dr. Hidde van der Ploeg

PI: Prof. dr. Willem van Mechelen, MD, PhD

Prof.dr. A. J. van der Beek

Dr. Jennifer Coffeng

ISMMS New York/ Madrid CNIC-PESA:

Global PI Valentin Fuster, MD, PhD/ Study PI: José M Castellano, MD, PhD/ Study PI: Borja Ibanez, MD, PhD/ Inés García Lunar, MD/ Sameer Bansilal, MD, PhD/ Antonio Fernández-Ortiz, MD, PhD/ Juan Miguel Fernández, PhD/ Laura García Leal/ Evelyn Cárdenas